Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma

Thomas Powles, Peter H. O’Donnell, Christophe Massard, +16

JAMA Oncology

Amyloid β and Amylin Fibrils Induce Increases in Proinflammatory Cytokine and Chemokine Production by THP‐1 Cells and Murine Microglia

Stephen L. Yates, Loyd H. Burgess, June Kocsis‐Angle, +5

Journal of Neurochemistry

Amyloid βSignal Transduction PathwaysImmunologyNeuroinflammationInflammation +17

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial

Tibor Csőszi, Marina Maglakelidze, Robert J. Hoyer, +24

Annals of Oncology

Safety and clinical activity of durvalumab monotherapy in patients with hepatocellular carcinoma (HCC).

Zev A. Wainberg, Neil H. Segal, Dirk Jaeger, +12

Journal of Clinical Oncology

ImmunologyPathologyTreatment-related AesPharmacotherapyImmunotherapeutics +22

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

Lowell L. Hart, Renata Ferrarotto, Zoran Andrić, +12

Advances in Therapy

Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial

Antoinette R. Tan, Gail S. Wright, Anu Thummala, +14

The Lancet Oncology

Chemotherapy Versus ChemotherapyBreast OncologyMedicineBreast CancerPharmacotherapy +5

Synthetic Surfactant (Exosurf) Inhibits Endotoxin-stimulated Cytokine Secretion by Human Alveolar Macrophages

Mary Jane Thomassen, David P. Meeker, Joyce Antal, +2

American Journal of Respiratory Cell and Molecular Biology

Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC

Scott Antonia, Ani Sarkis Balmanoukian, Julie R. Brahmer, +28

Journal of Thoracic Oncology

Trilaciclib prior to chemotherapy and atezolizumab in patients with newly diagnosed extensive‐stage small cell lung cancer: A multicentre, randomised, double‐blind, placebo‐controlled Phase <scp>II</scp> trial

Davey B. Daniel, Vladimer Kuchava, Igor Bondarenko, +10

International Journal of Cancer

Surfactant suppresses NF-kappa B activation in human monocytic cells.

Joyce Antal, L T Divis, Serpil C. Erzurum, +2

American Journal of Respiratory Cell and Molecular Biology

Pulmonary SurfactantInflammatory Lung DiseaseLung InflammationImmunologyImmune Regulation +17